Jefferies Group LLC Reaffirms “Buy” Rating for Varian Medical Systems, Inc. (VAR), Report finds

Jefferies Group LLC Reaffirms “Buy” Rating for Varian Medical Systems, Inc. (VAR), Report finds

Varian Medical Systems, Inc. (NYSE:VAR)‘s stock had its “buy” rating reaffirmed by analysts at Jefferies Group LLC in a report released on Wednesday. They currently have a $88.00 target price on the stock, down from their previous target price of $102.00. Jefferies Group LLC’s price objective indicates a potential upside of 11.10% from the company’s current price.

Other analysts have also issued research reports about the stock. RBC Capital Markets reiterated a “hold” rating on shares of Varian Medical Systems in a research note on Friday, January 6th. BTIG Research reissued a “hold” rating on shares of Varian Medical Systems in a report on Monday, October 31st. Zacks Investment Research downgraded shares of Varian Medical Systems from a “buy” rating to a “hold” rating in a report on Tuesday, October 25th. Aegis started coverage on shares of Varian Medical Systems in a report on Monday. They set a “hold” rating and a $85.00 price target for the company. Finally, Barrington Research boosted their price target on shares of Varian Medical Systems from $98.00 to $102.00 and gave the company an “outperform” rating in a report on Friday, January 27th. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and three have assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $92.23.

Varian Medical Systems (NYSE:VAR) traded up 0.99% during trading on Wednesday, reaching $79.21. 838,352 shares of the company’s stock traded hands. The stock has a market capitalization of $7.41 billion, a P/E ratio of 22.55 and a beta of 0.69. Varian Medical Systems has a 12 month low of $74.56 and a 12 month high of $106.69. The company has a 50-day moving average of $87.22 and a 200 day moving average of $92.22.

In related news, insider Dow R. Wilson sold 13,334 shares of the company’s stock in a transaction dated Thursday, January 5th. The shares were sold at an average price of $88.74, for a total value of $1,183,259.16. Following the completion of the sale, the insider now owns 77,625 shares of the company’s stock, valued at $6,888,442.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Dow R. Wilson sold 10,000 shares of the company’s stock in a transaction dated Monday, December 5th. The stock was sold at an average price of $90.03, for a total transaction of $900,300.00. Following the completion of the sale, the insider now directly owns 74,291 shares of the company’s stock, valued at approximately $6,688,418.73. The disclosure for this sale can be found here. Insiders sold 24,601 shares of company stock valued at $2,198,007 in the last ninety days. Corporate insiders own 0.91% of the company’s stock.

A number of large investors have recently modified their holdings of the company. Sumitomo Mitsui Asset Management Company LTD raised its position in shares of Varian Medical Systems by 0.4% in the second quarter. Sumitomo Mitsui Asset Management Company LTD now owns 7,604 shares of the company’s stock worth $625,000 after buying an additional 32 shares during the last quarter. Nuance Investments LLC purchased a new position in shares of Varian Medical Systems during the second quarter worth $4,416,000. Huntington National Bank raised its position in shares of Varian Medical Systems by 218.3% in the second quarter. Huntington National Bank now owns 2,378 shares of the company’s stock worth $196,000 after buying an additional 1,631 shares during the last quarter. South Texas Money Management Ltd. raised its position in shares of Varian Medical Systems by 2.5% in the second quarter. South Texas Money Management Ltd. now owns 305,803 shares of the company’s stock worth $25,146,000 after buying an additional 7,597 shares during the last quarter. Finally, Sumitomo Mitsui Trust Holdings Inc. raised its position in shares of Varian Medical Systems by 6.1% in the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 334,275 shares of the company’s stock worth $27,487,000 after buying an additional 19,306 shares during the last quarter. Hedge funds and other institutional investors own 99.95% of the company’s stock.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Related posts

Leave a Comment

Jefferies Group LLC Reaffirms “Buy” Rating for Varian Medical Systems, Inc. (VAR)

Jefferies Group LLC Reaffirms “Buy” Rating for Varian Medical Systems, Inc. (VAR)

Varian Medical Systems, Inc. (NYSE:VAR)‘s stock had its “buy” rating reaffirmed by analysts at Jefferies Group LLC in a report released on Wednesday. They currently have a $88.00 target price on the stock, down from their previous target price of $102.00. Jefferies Group LLC’s price objective indicates a potential upside of 11.10% from the company’s current price.

Other analysts have also issued research reports about the stock. RBC Capital Markets reiterated a “hold” rating on shares of Varian Medical Systems in a research note on Friday, January 6th. BTIG Research reissued a “hold” rating on shares of Varian Medical Systems in a report on Monday, October 31st. Zacks Investment Research downgraded shares of Varian Medical Systems from a “buy” rating to a “hold” rating in a report on Tuesday, October 25th. Aegis started coverage on shares of Varian Medical Systems in a report on Monday. They set a “hold” rating and a $85.00 price target for the company. Finally, Barrington Research boosted their price target on shares of Varian Medical Systems from $98.00 to $102.00 and gave the company an “outperform” rating in a report on Friday, January 27th. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and three have assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $92.23.

Varian Medical Systems (NYSE:VAR) traded up 0.99% during trading on Wednesday, reaching $79.21. 838,352 shares of the company’s stock traded hands. The stock has a market capitalization of $7.41 billion, a P/E ratio of 22.55 and a beta of 0.69. Varian Medical Systems has a 12 month low of $74.56 and a 12 month high of $106.69. The company has a 50-day moving average of $87.22 and a 200 day moving average of $92.22.

In related news, insider Dow R. Wilson sold 13,334 shares of the company’s stock in a transaction dated Thursday, January 5th. The shares were sold at an average price of $88.74, for a total value of $1,183,259.16. Following the completion of the sale, the insider now owns 77,625 shares of the company’s stock, valued at $6,888,442.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Dow R. Wilson sold 10,000 shares of the company’s stock in a transaction dated Monday, December 5th. The stock was sold at an average price of $90.03, for a total transaction of $900,300.00. Following the completion of the sale, the insider now directly owns 74,291 shares of the company’s stock, valued at approximately $6,688,418.73. The disclosure for this sale can be found here. Insiders sold 24,601 shares of company stock valued at $2,198,007 in the last ninety days. Corporate insiders own 0.91% of the company’s stock.

A number of large investors have recently modified their holdings of the company. Sumitomo Mitsui Asset Management Company LTD raised its position in shares of Varian Medical Systems by 0.4% in the second quarter. Sumitomo Mitsui Asset Management Company LTD now owns 7,604 shares of the company’s stock worth $625,000 after buying an additional 32 shares during the last quarter. Nuance Investments LLC purchased a new position in shares of Varian Medical Systems during the second quarter worth $4,416,000. Huntington National Bank raised its position in shares of Varian Medical Systems by 218.3% in the second quarter. Huntington National Bank now owns 2,378 shares of the company’s stock worth $196,000 after buying an additional 1,631 shares during the last quarter. South Texas Money Management Ltd. raised its position in shares of Varian Medical Systems by 2.5% in the second quarter. South Texas Money Management Ltd. now owns 305,803 shares of the company’s stock worth $25,146,000 after buying an additional 7,597 shares during the last quarter. Finally, Sumitomo Mitsui Trust Holdings Inc. raised its position in shares of Varian Medical Systems by 6.1% in the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 334,275 shares of the company’s stock worth $27,487,000 after buying an additional 19,306 shares during the last quarter. Hedge funds and other institutional investors own 99.95% of the company’s stock.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Related posts

Leave a Comment